| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 357704 | Cyanomorpholinodoxorubicin | 0.00863223795880985 | 0.52323314 |
| NSC 670664 | Null | 0.00863223795880985 | 0.13264065 |
| NSC 671392 | Null | 0.00863223795880985 | 0.25721782 |
| NSC 672215 | Null | 0.00863223795880985 | 0.40472788 |
| NSC 686583 | Null | 0.00863223795880985 | 0.39600631 |
| NSC 690270 | ANTINEOPLASTIC-690270 | 0.00863223795880985 | 0.45496835 |
| NSC 691127 | Null | 0.00863223795880985 | 0.41652345 |
| NSC 693986 | Pyrimidine-2,4(1H,3H)-dione, 1-[1,2-bis(ethoxycarbonyl)ethenyl]-5-methyl-3-propynyl-, (E)-, | 0.00863223795880985 | 0.20858553 |
| NSC 695590 | Null | 0.00863223795880985 | 0.56779133 |
| NSC 695941 | 6H-Imidazo[4,5,1-de]acridin-6-one, 5-[3-[[3-[[5-nitro-1,3-dioxo- 2H-benz[de]isoquinolin- 2-yl]propyl](methyl)amino]propyl]amino]-, dimethanesulfonate | 0.00863223795880985 | 0.57688734 |